Microangiopathic Hemolytic Anemia (MAHA) is a condition characterized by the destruction of red blood cells due to their passage through small, damaged blood vessels, often leading to hemolysis and anemia. It is commonly associated with conditions like Thrombotic Thrombocytopenic Purpura (TTP), Hemolytic Uremic Syndrome (HUS), and Disseminated Intravascular Coagulation (DIC).